Literature DB >> 22856558

Aptamer-containing surfaces for selective capture of CD4 expressing cells.

Qing Zhou1, Ying Liu, Dong-Sik Shin, Jaime Silangcruz, Nazgul Tuleuova, Alexander Revzin.   

Abstract

Aptamers have recently emerged as an excellent alternative to antibodies because of their inherent stability and ease of modification. In this paper, we describe the development of an aptamer-based surface for capture of cells expressing CD4 antigen. The glass or silicon surfaces were modified with amine-terminated silanes and then modified with thiolated RNA aptamer against CD4. Modification of the surface was first characterized by ellipsometry to demonstrate assembly of biointerface components and to show specific capture of recombinant CD4 protein. Subsequently, surfaces were challenged with model lymphocytes (cell lines) that were either positive or negative for CD4 antigen. Our experiments show that aptamer-functionalized surfaces have similar capture efficiency to substrates containing anti-CD4 antibody. To mimick capture of specific T-cells from a complex cell mixture, aptamer-modified surfaces were exposed to binary mixtures containing Molt-3 cells (CD4+) spiked into Daudi B cells (CD4-). 94% purity of CD4 cells was observed on aptamer-containing surfaces from an initial fraction of 15% of CD4. Given the importance of CD4 cell enumeration in HIV/AIDS diagnosis and monitoring, aptamer-based devices may offer an opportunity for novel cell detection strategies and may yield more robust and less expensive blood analysis devices in the future.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22856558      PMCID: PMC3538135          DOI: 10.1021/la2050338

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  39 in total

1.  Aptamer beacons for the direct detection of proteins.

Authors:  N Hamaguchi; A Ellington; M Stanton
Journal:  Anal Biochem       Date:  2001-07-15       Impact factor: 3.365

2.  Label-free electronic detection of thrombin in blood serum by using an aptamer-based sensor.

Authors:  Yi Xiao; Arica A Lubin; Alan J Heeger; Kevin W Plaxco
Journal:  Angew Chem Int Ed Engl       Date:  2005-08-26       Impact factor: 15.336

3.  Cell detection and counting through cell lysate impedance spectroscopy in microfluidic devices.

Authors:  Xuanhong Cheng; Yi-shao Liu; Daniel Irimia; Utkan Demirci; Liju Yang; Lee Zamir; William R Rodríguez; Mehmet Toner; Rashid Bashir
Journal:  Lab Chip       Date:  2007-05-11       Impact factor: 6.799

4.  A reagentless signal-on architecture for electronic, aptamer-based sensors via target-induced strand displacement.

Authors:  Yi Xiao; Brian D Piorek; Kevin W Plaxco; Alan J Heeger
Journal:  J Am Chem Soc       Date:  2005-12-28       Impact factor: 15.419

Review 5.  Using aptamers to visualize and capture cancer cells.

Authors:  Ying Pu; Zhi Zhu; Huixia Liu; Jiani Zhang; Jun Liu; Weihong Tan
Journal:  Anal Bioanal Chem       Date:  2010-05-18       Impact factor: 4.142

6.  Panning of multiple subsets of leukocytes on antibody-decorated poly(ethylene) glycol-coated glass slides.

Authors:  Kazuhiko Sekine; Alexander Revzin; Ronald G Tompkins; Mehmet Toner
Journal:  J Immunol Methods       Date:  2006-06-08       Impact factor: 2.303

Review 7.  The mucosal immune system: primary target for HIV infection and AIDS.

Authors:  R S Veazey; P A Marx; A A Lackner
Journal:  Trends Immunol       Date:  2001-11       Impact factor: 16.687

8.  A miniature cytometry platform for capture and characterization of T-lymphocytes from human blood.

Authors:  He Zhu; Monica Macal; Caroline N Jones; Michael D George; Satya Dandekar; Alexander Revzin
Journal:  Anal Chim Acta       Date:  2007-12-28       Impact factor: 6.558

9.  Aberrant lymphocyte activation precedes delayed virus-specific T-cell response after both primary infection and secondary exposure to hepadnavirus in the woodchuck model of hepatitis B virus infection.

Authors:  Shashi A Gujar; Adam K Jenkins; Clifford S Guy; Jinguo Wang; Tomasz I Michalak
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

10.  Enhancing the performance of a point-of-care CD4+ T-cell counting microchip through monocyte depletion for HIV/AIDS diagnostics.

Authors:  Xuanhong Cheng; Amit Gupta; Chihchen Chen; Ronald G Tompkins; William Rodriguez; Mehmet Toner
Journal:  Lab Chip       Date:  2009-02-04       Impact factor: 6.799

View more
  6 in total

Review 1.  Aptamers in HIV research diagnosis and therapy.

Authors:  Jyoti Bala; Srinivasan Chinnapaiyan; Rajib Kumar Dutta; Hoshang Unwalla
Journal:  RNA Biol       Date:  2018-02-12       Impact factor: 4.652

2.  Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cells.

Authors:  Nihal G Maremanda; Kislay Roy; Rupinder K Kanwar; Vidyarani Shyamsundar; Vijayalakshmi Ramshankar; Arvind Krishnamurthy; Subramanian Krishnakumar; Jagat R Kanwar
Journal:  Biomicrofluidics       Date:  2015-09-29       Impact factor: 2.800

Review 3.  Manipulating the in vivo immune response by targeted gene knockdown.

Authors:  Judy Lieberman
Journal:  Curr Opin Immunol       Date:  2015-07-03       Impact factor: 7.486

4.  Exclusion-Based Capture and Enumeration of CD4+ T Cells from Whole Blood for Low-Resource Settings.

Authors:  Alexander L Howard; Hannah M Pezzi; David J Beebe; Scott M Berry
Journal:  J Lab Autom       Date:  2013-10-18

Review 5.  Aptamers: active targeting ligands for cancer diagnosis and therapy.

Authors:  Xu Wu; Jiao Chen; Min Wu; Julia Xiaojun Zhao
Journal:  Theranostics       Date:  2015-01-20       Impact factor: 11.556

6.  Anti-CD antibody microarray for human leukocyte morphology examination allows analyzing rare cell populations and suggesting preliminary diagnosis in leukemia.

Authors:  Alina N Khvastunova; Sofya A Kuznetsova; Liubov S Al-Radi; Alexandra V Vylegzhanina; Anna O Zakirova; Olga S Fedyanina; Alexander V Filatov; Ivan A Vorobjev; Fazly Ataullakhanov
Journal:  Sci Rep       Date:  2015-07-27       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.